How much will Osimertinib cost after medical insurance in 2024? Will generic drugs be cheaper?

Osimertinib (Osimertinib), developed and produced by AstraZeneca in the UK, is an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) and a third-generation targeted anti-cancer drug. It is mainly used to treat patients with non-small cell lung cancer (NSCLC) who carry specific EGFR gene mutations. Osimertinib blocks the growth and spread of tumor cells by inhibiting the activity of EGFR receptors, thereby prolonging patients' survival and improving their quality of life. Currently, the cost of osimertinib has attracted much attention. How much will this drug cost after medical insurance in 2024? Will generic drugs be cheaper?

in the country, the medical insurance reimbursement policy provides substantial financial support to users of osimertinib. After reimbursement by medical insurance, the price of osimertinib will be significantly reduced compared to the original price, which will alleviate a lot of financial pressure on patients who require long-term treatment. However, it should be noted that medical insurance reimbursement usually has certain conditions, and patients need to meet specific indications and medication standards in order to enjoy medical insurance reimbursement. Therefore, patients should fully understand local medical insurance policies before use.

For patients with greater financial pressure, in addition to medical insurance reimbursement policies, generic drugs can also be considered. Generic drugs refer to drugs that are consistent with the original drugs in terms of active ingredients, dosage forms, administration routes, etc., but their prices are more affordable than the original drugs. In countries such as Laos, the production of generic drugs of osimertinib is relatively mature. Manufacturers such as Laos Lucius Pharmaceuticals, Laos United Pharmaceuticals, Laos Second Pharmaceutical Factory and Laos ASEAN Pharmaceuticals all produce generic drugs of osimertinib. The specifications of these generic drugs are 80mg*30 tablets, and a box is priced between 500 and 600 yuan, which is much lower than the price of the original drugs. However, there are many risks involved in purchasing drugs overseas, so you must purchase them through formal and legal channels. If in doubt, avoid it.

In summary, with the support of medical insurance policies, the price of osimertinib has been reduced, providing more patients with affordable treatment options. At the same time, generic drugs, as a more economical treatment option, provide patients with more medication options. However, no matter which drug is chosen, patients should ensure the safety and effectiveness of the medication under the guidance of a doctor.